Carl Haslam

Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis

Damian J. Mole, Scott P. Webster, Iain Uings et al. · Nature Medicine · 2016 · 160 citations · Full text

Medicine, Biochemistry, Pharmacology +8

The Evolution of MALDI-TOF Mass Spectrometry toward Ultra-High-Throughput Screening: 1536-Well Format and Beyond

Carl Haslam, John Hellicar, Adrian J. Dunn et al. · SLAS DISCOVERY · 2015 · 144 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +16

Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor et al. · Journal of Medicinal Chemistry · 2007 · 120 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist

Andrew J. Brown, Dion A. Daniels, Mumta Kassim et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 73 citations

Medicine, Biochemistry, Pharmacology +17

Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Derivatives

Susan M. Westaway, Alex Preston, Michael D. Barker et al. · Journal of Medicinal Chemistry · 2016 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9